Aladashvili Giorgi, Nebieridze Anano, Pkhakadze Giorgi, Nadareishvili Ilia
School of Public Health David Tvildiani Medical University Tbilisi Georgia.
Public Health Chall. 2022 Dec;1(4):e46. doi: 10.1002/puh2.46. Epub 2022 Dec 12.
The COVID-19 vaccination program in the country of Georgia began on March 15, 2021, and reached its peak in the summer of 2021. Throughout the process, individuals had access to over 5.3 million doses of COVID-19 vaccines which were acquired from various sources as reported by the National Center for Disease Control and Public Health (NCDC). Factors such as widespread vaccine hesitancy and low demand led to reduced vaccine uptake, low vaccination rates, and vaccine wastage. As of August 2022, a total of 2,922,000 doses have been administered with less than 35% of the Georgian population, or 1,276,000 people, fully vaccinated with at least two doses. Over 400,000 doses have expired at NCDC's storage facilities due to low demand. Many more doses have been wasted at administration points, and there is a risk of wasting more in the future. The key reasons for wastage are widespread public hesitancy toward the newly developed vaccines, inconsistent policies and communication from government officials, rampant disinformation, and ambiguity from influential bodies in Georgian society. Despite certain limitations, logistics is not among the leading causes of wastage, as Georgia was able to develop a strong cold-chain and vaccine administration infrastructure through years of international cooperation that allowed for efficient management of the COVID-19 vaccination process. Lastly, in addition to establishing a robust reporting system and ensuring transparency of vaccine wastage data, relevant studies based on original data are required to better understand the problem. Conducting studies on health literacy in the country as a baseline for long-term interventions, as well as research that will increasingly evidence-inform further pandemic response are being recommended.
格鲁吉亚的新冠疫苗接种计划于2021年3月15日启动,并在2021年夏季达到高峰。在整个过程中,根据国家疾病控制和公共卫生中心(NCDC)的报告,个人可以获得超过530万剂从各种来源获取的新冠疫苗。广泛存在的疫苗犹豫情绪和低需求等因素导致疫苗接种率降低、接种率低以及疫苗浪费。截至2022年8月,共接种了292.2万剂,格鲁吉亚人口中不到35%(即127.6万人)完成了至少两剂的全程接种。由于需求低,NCDC储存设施中有超过40万剂疫苗过期。在接种点浪费了更多剂量,未来还有更多浪费的风险。浪费的主要原因是公众对新研发疫苗普遍存在犹豫情绪、政府官员政策和沟通不一致、虚假信息泛滥以及格鲁吉亚社会有影响力的机构态度模糊。尽管存在某些限制,但物流并非浪费的主要原因之一,因为格鲁吉亚通过多年的国际合作建立了强大的冷链和疫苗接种基础设施,能够有效管理新冠疫苗接种过程。最后,除了建立强大的报告系统并确保疫苗浪费数据的透明度外,还需要基于原始数据的相关研究来更好地理解这个问题。建议开展关于该国健康素养的研究作为长期干预的基线,以及开展越来越多以证据为依据为进一步应对疫情提供信息的研究。